Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewGeneticsOncology Open Access | 10.1172/JCI195334

Patient-Derived Xenograft Models of Fanconi Anemia-Associated Head and Neck Cancer Identify Personalized Therapeutic Strategies

Jennifer Grandis,1 Hua Li,1 Benjamin A. Harrison,2 Andrew L.H. Webster,2 Joanna Pucilowska,3 Austin Nguyen,3 Jinho Lee,3 Gordon B. Mills,3 Jovanka Gencel-Augusto,1 Yan Zeng,1 Steven R. Long,4 Mi-Ok Kim,5 Rex H. Lee,1 David I. Kutler,6 Theresa Scognamiglio,7 Margaret Brandwein-Weber,8 Mark Urken,9 Inna Khodos,10 Elisa de Stanchina,10 Yu-Chien Lin,2 Frank X. Donovan,11 Settara C. Chandrasekharappa,11 Moonjung Jung,2 Mathijs A. Sanders,12 Agata Smogorzewska,2 and Daniel E. Johnson1

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Grandis, J. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Li, H. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Harrison, B. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Webster, A. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Pucilowska, J. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Nguyen, A. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Lee, J. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Mills, G. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Gencel-Augusto, J. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Zeng, Y. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Long, S. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Kim, M. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Lee, R. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Kutler, D. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Scognamiglio, T. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Brandwein-Weber, M. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Urken, M. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Khodos, I. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by de Stanchina, E. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Lin, Y. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Donovan, F. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Chandrasekharappa, S. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Jung, M. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Sanders, M. in: PubMed | Google Scholar

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Smogorzewska, A. in: PubMed | Google Scholar |

1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America

2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America

3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America

4Department of Pathology, University of California San Francisco, San Francisco, United States of America

5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America

6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America

7Department of Pathology, Weill Cornell Medical College, New York, United States of America

8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America

9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America

10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America

11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America

12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Find articles by Johnson, D. in: PubMed | Google Scholar |

Published December 16, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI195334.
Copyright © 2025, Grandis et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published December 16, 2025 - Version history
View PDF
Abstract

Fanconi anemia (FA) confers a high risk (~700-fold increase) of solid tumor formation, most often head and neck squamous cell carcinoma (HNSCC). FA germline DNA repair defects preclude administration of most chemotherapies and prior hematopoietic stem cell transplantation limits use of immunotherapy. Thus, surgery and judicious delivery of radiation offer the only treatment options, with most patients succumbing to their cancers. A paucity of preclinical models has limited the development of new treatments. Here, we report, to our knowledge, the first patient-derived xenografts (PDXs) of FA-HNSCC and highlight the efficacy of FDA-approved EGFR targeted therapies in tumors with high EGFR/p-EGFR levels and the activity of the FDA-approved Bcl-2 inhibitor venetoclax in a FA-HNSCC PDX overexpressing Bcl-2. These findings support the development of precision medicine approaches for FA-HNSCC.

Supplemental material

View

View

View Supplemental Figure 1

View Supplemental Figure 2

View Supplemental Figure 3

View Supplemental Figure 4

View Supplemental Figure 5

View Supplemental Figure 6

View Supplemental Figure 7

Version history
  • Version 1 (December 16, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts